Historical spirals of intrathecal therapy of bacterial meningoencephalites: from past to present

Authors

  • Сергей Петрович Борщев SE « L.V. Gromashevskiy's Institute of Epidemiology and Infectious Diseases of NAMS of Ukraine» 4 Galycka str., Kiev, Ukraine, 04123, Ukraine https://orcid.org/0000-0001-8284-8045

DOI:

https://doi.org/10.15587/2313-8416.2015.52061

Keywords:

intrathecal therapy, bacterial meningoencephalites, history, study prospects

Abstract

On the base of studying medical literature in the article was considered the history of using intrathecal methods of bacterial meningoencephalites therapy, using intrathecal methods in other medical fields, the modern state of problem.

Aim of research: To study the history of using intrathecal methods of bacterial meningoencephalites therapy, the state of problem in the world, an experience of using intrathecal therapeutical methods in other medical fields and to define prospects and necessity of further scientific researches in this direction.

Materials and methods: There were used scientometric data bases, available scientific medical printing editions, historical, analytical, philosophical methods, analysis and generalization, the cause-and-effect relations, logic, dialectic.

Results of research: There were revealed regularities of growth and decline of interest of medical community to this problem. For today there is no unambiguous attitude to intrathecal therapy of bacterial meningoencephalites. There are contrary opinions about necessity of using this method. There were revealed objective factors that complicate the development of researches in the field of intrathecal therapy of bacterial meningoencephalites.

Conclusions: 1. Intrathecal methods of administration preparations at treating patients with bacterial meningoencephalites were successfully used from the beginning of 20 century.

2. The degree of interest of medical scientific community to intrathecal therapeutical methods depended on objective necessity of its use in different medical fields at the concrete historical stage.

3. Attention to intrathecal methods of treatment decreased as an effect of discovery new antibacterial preparations

4. From historical point of view the spread of intrathecal methods of treatment depends on toxicity and effectiveness of preparations for the system use: the higher toxicity and less effectiveness of the system therapy, the more spread use of intrathecal methods.

5. At present an observed decrease of effectiveness of the system antibiotic therapy of meningoencephalites as the result of change in structure of disease and development of antibiotic resistance inevitably must increase an attention of medical scientific community to studying intrathecal therapeutical methods.

6. The researches in the field of intrathecal therapy at bacterial meningoencephalites are actual and promising at the present time

Author Biography

Сергей Петрович Борщев, SE « L.V. Gromashevskiy's Institute of Epidemiology and Infectious Diseases of NAMS of Ukraine» 4 Galycka str., Kiev, Ukraine, 04123

Candidate of Medical Sciences, Senior researcher

Department of intensive therapy and detoxification

References

Sorokina, M. N., Ivanova, V. V., Skripchenko, N. V. (2003). Bakterial'nye meningity u detej. Moscow: Medicina, 320.

Cenzerling, V. A., Chuhlovina, M. L. (2005). Infekcionnye porazhenija nervnoj sistemy. Sankt–Peterburg: Uzd. ELBI-SPb, 48.

Flexner, S. (1913). The results of the serum treatment in thirteen hundred cases of epidemic meningitis. Journal of Experimental Medicine, 17 (5), 553–576. doi: 10.1084/jem.17.5.553

Fothergill, L. R. D. (1937). Hemophilus influenzae (Pfeiffer Bacillus) Meningitis and Its Specific Treatment. New England Journal of Medicine, 216 (14), 587–590. doi: 10.1056/nejm193704082161401

Alexander, H. E. (1943). Treatment Of Haemophilus Influenzae Infections And Of Meningococcic And Pneumococcic Meningitis. Archives Of Pediatrics & Adolescent Medicine, 66 (2), 172–187. doi: 10.1001/Archpedi.1943.02010200074010

Fridman, A. P. (1971). Osnovy likvorologii (uchenie o zhidkosti mozga). Leningrad: Medicina, 633–639.

Dowlinc, H. F., Sweet, L. K., Robinson, J. A., Zellers, W. W., Hirsh, H. L. (1949). The Treatment Of Pneumococcic Meningitis With Massive Doses Of Systemic Penicillin. The American Journal Of The Medical Sciences, 217 (2), 149–156. doi: 10.1097/00000441-194902000-00005

Shifman, E. M., Filippovich, G. V. (2008). Jevoljucija teorii i praktiki obezbolivanija rodov. Regionarnaja anestezija i lechenie ostroj boli, 2 (4), 43–52.

Krasnov, V. G., Kirienko, P. A., Suhanov, I. I., Gel'fand, B. R., Shirjaev, M. I. (2007). Subarahnoidal'naja anestezija pri jekstrennom abdominal'nom rodorazreshenii. Anesteziologija i reanimatologija, 6, 33–36.

Kaz'min, S. N., Kozlov, S. P., Zolicheva, N. Ju., Svetlova, V. A. (2006). Subarahnoidal'naja anestezija u bol'nyh s soputstvujushhimi zabolevanijami serdechno-sosudistoj sistemy s vysokim operacionnym riskom. Anesteziologija i reanimatologija, 5, 44–48.

Shifman, E. M., Filippovich, G. V. (2003). Bezopasnost' subarahnoidal'noj anestezii pri kesarevom sechenii u beremennyh s prejeklampsiej. Anesteziologija i reanimatologija, 5, 38–41.

Shlapak, I. P. (1994). Kombinova spinal'na opioidna anestezija/analgezija ta i'i' ocinka jak metodu adekvatnogo antynociceptyvnogo zahystu. Kyiv, 42.

Roy, J.-D., Massicotte, L., Sassine, M.-P., Seal, R. F., Roy, A. (2006). A Comparison of Intrathecal Morphine/Fentanyl and Patient-Controlled Analgesia with Patient-Controlled Analgesia Alone for Analgesia After Liver Resection. Anesthesia & Analgesia, 103 (4), 990–994. doi: 10.1213/01.ane.0000238040.41872.7e

Sarvela, J., Halonen, P., Soikkeli, A., Korttila, K. (2002). A Double-Blinded, Randomized Comparison of Intrathecal and Epidural Morphine for Elective Cesarean Delivery. Anesthesia & Analgesia, 95 (2), 436–440. doi: 10.1213/00000539-200208000-00037

Kim, S. Y., Cho, J. E., Hong, J. Y., Koo, B. N., Kim, J. M., Kil, H. K. (2009). Comparison of intrathecal fentanyl and sufentanil in low-dose dilute bupivacaine spinal anaesthesia for transurethral prostatectomy. British Journal of Anaesthesia, 103 (5), 750–754. doi: 10.1093/bja/aep263

Celeski, D. C., Heindel, L., Haas, J., Vacchiano, C. A. (1999). Effect of intrathecal fentanyl dose on the duration of labor analgesia. AANA J., 67 (3), 239–244.

Leighton, B. L., DeSimone, C. A., Norris, M. C., Ben-David, B. (1989). Intrathecal Narcotics for Labor Revisited. Anesthesia & Analgesia, 69 (1), 122–125. doi: 10.1213/00000539-198907000-00023

Rust, L. A., Waring, R. W., Hall, G. L., Nelson, E. I. (1994). Intrathecal narcotics for obstetric analgesia in a community hospital. American Journal of Obstetrics and Gynecology, 170 (6), 1643–1648. doi: 10.1016/s0002-9378(94)70335-3

Lim, Y., Ocampo, C. E., Sia, A. T. (2004). A Comparison of Duration of Analgesia of Intrathecal 2.5 mg of Bupivacaine, Ropivacaine, and Levobupivacaine in Combined Spinal Epidural Analgesia for Patients in Labor. Anesthesia & Analgesia, 98 (1), 235–239. doi: 10.1213/01.ane.0000094338.80430.c5

Richardson, L., Dunning, J., Hunter, S. (2008). Is intrathecal morphine of benefit to patients undergoing cardiac surgery. Interactive CardioVascular and Thoracic Surgery, 8 (1), 117–122. doi: 10.1510/icvts.2008.190686

Kara, I., Apiliogullari, S., Oc, B., Celik, J., Duman, A., Celik, C., Dogan, N. (2012). The Effects of Intrathecal Morphine on Patient-Controlled Analgesia, Morphine Consumption, Postoperative Pain and Satisfaction Scores in Patients Undergoing Gynaecological Oncological Surgery. Journal of International Medical Research, 40 (2), 666–672. doi: 10.1177/147323001204000229

Wu, J. L., Hsu, M. S., Hsu, T. C., Chen, L. H., Yang, W. J., Tsai, Y. C. (1997). The efficacy of intrathecal coadministration of morphine and bupivacaine for labor analgesia. Acta Anaesthesiol. Sin., 35 (4), 209–216.

Zakkar, M., Tan, C., Hunt, I. (2013). 045 * The Role Of Preoperative Intrathecal Diamorphine Injection In Thoracic Surgery: Single-Unit Experience. Interactive CardioVascular and Thoracic Surgery, 17, S79–S79. doi: 10.1093/icvts/ivt372.45

Upadhyay, S. P., Mallick, P. N. (2011). Intrathecal Drug Delivery System (IDDS) for Cancer Pain Management: A Review and Updates. American Journal of Hospice and Palliative Medicine, 29 (5), 388–398. doi: 10.1177/1049909111426134

Tucker, A. P., Mezzatesta, J., Nadeson, R., Goodchild, C. S. (2004). Intrathecal Midazolam II: Combination with Intrathecal Fentanyl for Labor Pain. Anesthesia & Analgesia, 98 (6), 1521–1527. doi: 10.1213/01.ane.0000112434.68702.e4

Ghafoor, V. L., Epshteyn, M., Carlson, G. H., Terhaar, D. M., Charry, O., Phelps, P. K. (2007). Intrathecal drug therapy for long-term pain management. American Journal of Health-System Pharmacy, 64 (23), 2447–2461. doi: 10.2146/ajhp060204

Ginosar, Y., Riley, E. T., Angst, M. S. (2013). Analgesic and sympatholytic effects of low-dose intrathecal clonidine compared with bupivacaine: a dose-response study in female volunteers. British Journal of Anaesthesia, 111 (2), 256–263. doi: 10.1093/bja/aet027

Van der Plas, A. A., van Rijn, M. A., Marinus, J., Putter, H., van Hilten, J. J. (2013). Efficacy of Intrathecal Baclofen on Different Pain Qualities in Complex Regional Pain Syndrome. Anesthesia & Analgesia, 116 (1), 211–215. doi: 10.1213/ane.0b013e31826f0a2e

Engelman, E., Marsala, C. (2012). Efficacy of adding clonidine to intrathecal morphine in acute postoperative pain: meta-analysis. British Journal of Anaesthesia, 110 (1), 21–27. doi: 10.1093/bja/aes344

Zeeliger, A., Mel'nik, N. Ju. (2008). Ocenka jeffektivnosti dlitel'nosti intratekal'noj terapii rezistentnih bolevyh sindromov. Ukrains'kij nejrohіrurgіchnij zhurnal, 2, 56–60.

Arakawa, M. (2003). Intrathecal Magnesium Prolongs Fentanyl Analgesia. Anesthesia & Analgesia, 96 (5), 1533. doi: 10.1213/01.ane.0000058162.70154.bd

Leonov, O. V., Shirokorad, V. I., Dolgih, V. T. et. al (2003). Jendoljumbal'naja gormonal'naja terapija v palliativnom lechenii bol'nyh s disseminirovannym rakom predstatel'noj zhelezy. Jefferentnaja terapija, 9 (3), 53–57.

Lin, N., Dunn, I. F., Glantz, M., Allison, D. L., Jensen, R., Johnson, M. D. et. al (2011). Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study. Journal of Neurosurgery, 115 (4), 730–736. doi: 10.3171/2011.5.jns101768

Duarte, R. F., Arnan, M., Sánchez-Ortega, I., de Llano, M. P. Q., Abellán, P. F. (2011). Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia. Leukemia Research, 35 (7), e128–e130. doi: 10.1016/j.leukres.2011.03.023

Benesch, M., Sovinz, P., Krammer, B., Lackner, H., Mann, G., Schwinger, W. et. al (2007). Feasibility and Toxicity of Intrathecal Liposomal Cytarabine in 5 Children and Young Adults With Refractory Neoplastic Meningitis. Journal of Pediatric Hematology/Oncology, 29 (4), 222–226. doi: 10.1097/mph.0b013e318041f112

Rebischung, C., Hoffmann, D., Stéfani, L., Desruet, M. D., Wang, K., Adelstein, S. J. et. al (2008). First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX Plus 125 IUdR. International Journal of Radiation Biology, 84 (12), 1123–1129. doi: 10.1080/09553000802395535

Romani, C., Di Tucci, A. A., Dessalvi, P., Pettinau, M., Emanuele, A. (2010). Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience. American Journal of Hematology, 85 (3), 219. doi: 10.1002/ajh.21606

Brion, A., Legrand, F., Larosa, F., Schillinger, F., Garnache-Ottou, F., Helias, P. et. al (2011). Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis. Investigational New Drugs, 30 (4), 1697–1702. doi: 10.1007/s10637-011-9632-6

Gammon, D. C., Bhatt, M. S., Tran, L., Van Horn, A., Benvenuti, M., Glantz, M. J. (2006). Intrathecal topotecan in adult patients with neoplastic meningitis. American Journal of Health-System Pharmacy, 63 (21), 2083–2086. doi: 10.2146/ajhp060165

Perissinotti, A. J., Reeves, D. J. (2010). Role of Intrathecal Rituximab and Trastuzumab in the Management of Leptomeningeal Carcinomatosis. Annals of Pharmacotherapy, 44 (10), 1633–1640. doi: 10.1345/aph.1p197

Bernardi, R. J., Bomgaars, L., Fox, E., Balis, F. M., Egorin, M. J., Lagattuta, T. F. et. al (2007). Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis. Cancer Chemotherapy and Pharmacology, 62 (2), 355–361. doi: 10.1007/s00280-007-0601-x

Colagrande, M., Ianni, M. D., Ciurnelli, R., Gallucci, M., Mariani, G., Tabilio, A. (2007). Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis. British Journal of Haematology, 138 (6), 812–813. doi: 10.1111/j.1365-2141.2007.06712.x

Niemann, A., Mühlisch, J., Frühwald, M. C., Ger, J., Hempel, G., Boos, J. (2010). Therapeutic Drug Monitoring of Methotrexate in Cerebrospinal Fluid After Systemic High-Dose Infusion in Children: Can the Burden of Intrathecal Methotrexate be Reduced? Therapeutic Drug Monitoring, 32 (4), 467–475. doi: 10.1097/ftd.0b013e3181e5c6b3

Matjash, V. I. (1990). Klinicheskie osobennosti i principy terapii bakterial'nyh meningojencefalitov u lic pozhilogo i starcheskogo vozrasta. Kyiv, 19.

Kulikov, A. V., Panov, V. V. (1997). Opyt intrakarotidnogo primenenija meropenema pri terapii vtorichnogo gnojnogo meningita. Zdravoohranenie segodnja, 7, 28.

Swartz, M. N. (2004). Bacterial Meningitis: A View of the Past 90 Years. New England Journal of Medicine, 351 (18), 1826–1828. doi: 10.1056/nejmp048246

Kubrakov, K. M., Kosinec, A. N., Akulenok, A. V. (2008). Intratekal'noe vvedenie antibakterial'nyh preparatov u nejrohirurgicheskih bol'nyh s meningojencefalitami. Novosti hirurgii, 16 (4), 86–93.

Berning, S. E., Cherry, T. A., Iseman, M. D. (2001). Novel Treatment of Meningitis Caused by Multidrug-Resistant Mycobacterium tuberculosis with Intrathecal Levofloxacin and Amikacin: Case Report. Clinical Infectious Diseases, 32 (4), 643–646. doi: 10.1086/318698

Falagas, M. E., Bliziotis, I. A., Tam, V. H. (2007). Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. International Journal of Antimicrobial Agents, 29 (1), 9–25. doi: 10.1016/j.ijantimicag.2006.08.024

Glick, J. A., Graham, R. S., Voils, S. A. (2009). Candida Meningitis Post Gliadel Wafer Placement Successfully Treated with Intrathecal and Intravenous Amphotericin B. Annals of Pharmacotherapy, 44 (1), 215–218. doi: 10.1345/aph.1m453

Ho, Y.-H., Wang, L. S., Chao, H. J., Chang, K. C., Su, C. F. (2007). Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J. Microbiol. Immunol. Infect., 40 (6), 537–540.

Yuchong, C., Jianghan, C., Hai, W., Julin, G. (2010). Lumbar puncture drainage with intrathecal injection of amphotericin B for control of cryptococcal meningitis. Mycoses, 54 (4), e248–e251. doi: 10.1111/j.1439-0507.2009.01847.x

Al Shirawi, N., Memish, Z. A., Cherfan, A., Al Shimemeri, A. (2006). Post-Neurosurgical Meningitis Due to Multidrug-Resistant Acinetobacter baumanii Treated with Intrathecal Colistin: Case Report and Review of the Literature. Journal of Chemotherapy, 18 (5), 554–558. doi: 10.1179/joc.2006.18.5.554

Goto, K., Ohi, T., Namba, A., Uemura, N., Kitaguchi, H. (2011). Successful treatment of methicillin–resistant staphylococcus aureus meningitis by intrathecal injection of vancomycin. Brain Nerve., 63 (4), 417–421.

Varelas, P. N., Rehman, M., Pierce, W., Wellwood, J., Chua, T., Revankar, S. (2008). Vancomycin-resistant enterococcal meningitis treated with intrathecal streptomycin. Clinical Neurology and Neurosurgery, 110 (4), 376–380. doi: 10.1016/j.clineuro.2007.11.005

Sagar, S., Makgir, D.; Samujel'sa, M. (Ed.) (1997). Bakterial'nyj meningit. Nevrologija. Moscow: Praktika, 193–230.

Carenko, S. V. (2007). Nejroreanimatologija v nachale novogo tysjacheletija. Medicina neotlozhnyh sostojanij, № 2 (9), 16–22.

Senbaga, N., Davies, E. M. (2005). Inadvertent intrathecal administration of rifampicin. British Journal of Clinical Pharmacology, 60 (1), 116–116. doi: 10.1111/j.1365-2125.2005.02405.x

Published

2015-10-30

Issue

Section

Medical Science. Part 2